X4 Pharmaceuticals (XFOR) Reports Q3 Loss, Misses Revenue Estimates

X4 Pharmaceuticals (XFOR) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of$ 0.79. This compares to a loss of $5.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +12.66%. A quarter ago, it was expected that this company would post a loss of$ 4.53 per share when it actually produced a loss of $3.47, delivering a surprise of +23.4%.Over the last four quarters, the company has su ...